Table 1—

Clinical characteristics of all patients included in the study

Type 1 diabetic subjects monitored with CGMSType 1 diabetic nonmonitored control subjectsType 2 diabetic subjects monitored with CGMS
n403530
Sex (M/F)18/2217/1817/13
Age (years)36.5 ± 1241 ± 1058 ± 11
Diabetes duration (years)17 ± 1221 ± 1012 ± 8
HbA1c (%)8.3 ± 1.68.0 ± 1.47.4 ± 1.6
TreatmentAll with MIIAll with MII9 oral drugs, 20 MII, 1 CSII
  • Data are means ± SD, unless otherwise indicated. Oral drugs: metformin alone or in combination with sulphonylureas.